Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma
Fields of Study & Subjects
Extracellular vesicles in disease
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Publication details
- Journal / source
- Nature Biotechnology
- Publisher
- Springer Science and Business Media LLC
- Publication date
- 5 January 2026
- Language
- EN